Science and Engineering Ethics

, Volume 18, Issue 2, pp 263–284

It’s About Scientific Secrecy, Dummy: A Better Equilibrium Among Genomics Patenting, Scientific Research and Health Care

Article

DOI: 10.1007/s11948-011-9257-3

Cite this article as:
Bentwich, M. Sci Eng Ethics (2012) 18: 263. doi:10.1007/s11948-011-9257-3
  • 151 Views

Abstract

This paper offers a different pragmatic and patent-based approach to concerns regarding the negative effects of genetic-based patenting on advancing scientific research and providing adequate and accessible health care services. At the basis of this approach lies an explication of a mandatory provisional patented paper procedure (PPPA), designed for genetic-based patents and administered by leading scientific journals in the field, while officially acknowledged by the USPTO, and subsequently by other patent offices as well. It is argued that the uniqueness of PPPAs lies in subsequently mitigating the negative ramifications of genetic patents on scientific research and genetic-based health care services, while basing such mitigation on a patents’ advocate viewpoint that neither discards the patent system nor jeopardizes its integrity.

Keywords

PatentsChallengeScientific researchHealth careResolution

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  1. 1.Faculty of Health SciencesBen Gurion UniversityBeer ShevaIsrael